Company
Founded in September 2019, we are a team of experienced AI/machine learning and business specialists applying state of the art generative AI to drug discovery in close collaboration with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.
Our Team
We are a team of experienced AI/machine learning and business specialists applying state of the art generative AI to drug discovery in close collaboration with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.
Board, Observers, and Advisors
Funding, Partners & Investors
Founded in September 2019, we are a team of experienced AI/machine learning and business specialists applying state of the art generative AI to drug discovery in close collaboration with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.
In the Press
Recent News & Events

Variational AI Files Two US Provisional Patents for Potential COVID-19 Drug Created by Generative AI

Variational AI Adds Jennifer Hamilton as Advisor

Variational AI Adds Leading Oncology Researchers to Scientific Advisory Board

Variational AI is hiring!
Please see open job listing below or contact us if you would like to join the team in the area of machine learning, computational medicinal chemistry, and business development.